Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia

Published:2013-12-06 Issue:6 Volume:28 Page:1196-1206
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Lonetti A,Antunes I L,Chiarini F,Orsini E,Buontempo F,Ricci F,Tazzari P L,Pagliaro P,Melchionda F,Pession A,Bertaina A,Locatelli F,McCubrey J A,Barata J T,Martelli A M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013369.pdf

Reference60 articles.

1. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES . The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117: 5019–5032.

2. Pui CH, Robison LL, Look AT . Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030–1043.

3. Alharbi RA, Pettengell R, Pandha HS, Morgan R . The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia 2013; 27: 1000–1008.

4. Iacobucci I, Papayannidis C, Lonetti A, Ferrari A, Baccarani M, Martinelli G . Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments. Curr Hematol Malig Rep 2012; 7: 133–143.

5. Bains T, Heinrich MC, Loriaux MM, Beadling C, Nelson D, Warrick A et al. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Leukemia 2012; 26: 2144–2146.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection;Current Hematologic Malignancy Reports;2024-06-13

2. New Directions for Treating Tumors: Scientific Context;IFMBE Proceedings;2024

3. In the Pipeline—Emerging Therapy for ALL;Pathogenesis and Treatment of Leukemia;2023

4. T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development;Expert Opinion on Investigational Drugs;2022-12-28

5. Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines;Cells;2022-06-29